Answers are grounded in this paper and cite their sources.
To assess the safety and effectiveness of turoctocog alfa in previously treated patients (PTPs) and previously untreated patients (PUPs) with haemophilia A in a real-world setting in Japan.
No takes yet. Share an insight, caveat, or question.
Nagao et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: